Cyclopentolate
Back to searchMolecule Structure
Scientific Name
Cyclopentolate
Description of the Drug
Cyclopentolate is an anticholinergic used to cause mydriasis and cycloplegia for diagnostic testing.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00979
http://www.drugbank.ca/drugs/DB00979
Brand Name(s)
Not Available
Company Owner(s)
Sola Barnes Hind, Bausch And Lomb Pharmaceuticals Inc, Alcon Pharmaceuticals Ltd, Pharmafair Inc, Alcon Laboratories Inc, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL132500 | ||
| PharmGKB | PA164743019 | ||
| Human Metabolome Database | HMDB0015114 | ||
| DrugBank | DB00979 | ||
| PubChem: Thomson Pharma | 15270905 | ||
| PubChem | 2905 | ||
| LINCS | LSM-1800 | ||
| Nikkaji | J264.904G | J6.274J | J264.905E |
| BindingDB | 82375 | ||
| EPA CompTox Dashboard | DTXSID3048528 | ||
| DrugCentral | 757 | ||
| ChemicalBook | CB9707085 | ||
| Guide to Pharmacology | 7153 | ||
| rxnorm | CYCLOPENTOLATE | CYCLOPENTOLATE HYDROCHLORIDE | CYCLOGYL |
| KEGG Ligand | C06932 | ||
| ChEBI | 4024 |
